Intraosseous Spindle Cell Rhabdomyosarcoma With Tfcp2 Ncoa2 Rearrangements C5554888
A rare bone cancer involving specific genetic changes. It typically occurs in young people. Treatment involves surgery, chemotherapy, and radiation depending on spread.
Key facts at a glance
- ICD-10
- C80.1
- ICD-11
- 2A00.0
- Body system
- oncologic
- Severity
- severe
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Pathologic fracture
Generalized symptoms
(oncologic)Significant symptoms that substantially affect daily functioning.
Frequency: Common at all stages
Localized bone pain
(Musculoskeletal)Swelling over the affected bone
(Musculoskeletal)Limited range of motion
(Musculoskeletal)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Multi-agent Chemotherapy
Intensive chemotherapy regimens combining multiple anticancer drugs to target the rhabdomyosarcoma cells. This is the cornerstone of treatment for this aggressive malignancy and is typically given before and/or after surgery.
Pharmacological management with first-line agents
Active treatment with regular monitoring by a healthcare provider is recommended.
Surgical Tumor Resection
Surgical removal of the tumor with adequate margins when anatomically feasible, aiming for complete resection while preserving limb function and structural integrity of the affected bone.
Additional treatment options
Radiation Therapy
Targeted radiation to destroy remaining cancer cells after surgery or when complete surgical resection is not possible. Helps reduce local recurrence risk in this aggressive tumor type.
procedureOncologic Surveillance and Imaging
Regular imaging studies including MRI and CT scans, along with tumor markers and clinical examinations to detect recurrence early and monitor treatment response throughout the care continuum.
monitoringRehabilitation and Functional Restoration
Comprehensive rehabilitation including physical therapy, occupational therapy, and possibly prosthetics consultation to maximize functional recovery following surgical treatment and maintain quality of life.
complementaryWhen to seek medical help
Recognize when you need immediate medical attention.
See a doctor within 24 hours
Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.
Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.
Frequently asked questions
Common questions about this topic.
What is Intraosseous Spindle Cell Rhabdomyosarcoma With Tfcp2 Ncoa2 Rearrangements C5554888?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalMedication Comparisons
Compare medications used to treat Intraosseous Spindle Cell Rhabdomyosarcoma With Tfcp2 Ncoa2 Rearrangements C5554888. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy